Αποτελέσματα Αναζήτησης
Introduction. Hospital-acquired pneumonia (HAP) is an infection of the pulmonary parenchyma caused by pathogens that are present in hospital settings [1]. Nosocomial pneumonia develops in patients admitted to the hospital for >48 h and usually the incubation period is at least 2 days.
- Inducible Laryngeal Obstruction
Inducible laryngeal obstruction (ILO) describes an...
- Official ERS Technical Standards
There are numerous reference equations available for the...
- Inducible Laryngeal Obstruction
26 Ιουν 2018 · Nosocomial pneumonia is a frequent infection that is classified into two groups [1]: HAP, which develops in hospitalised patients after 48 h of admission, and does not require (but may include) artificial ventilation at the time of diagnosis [2, 3]; and VAP, which occurs in intensive care unit (ICU) patients who have received mechanical ventilat...
26 Ιουν 2023 · Nosocomial pneumonia or hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs 48 hours or more after hospital admission and is not present at the admission time. Ventilator-associated pneumonia (VAP) represents a significant subset of HAP occurring in intensive care units (ICUs).
14 Ιουλ 2016 · These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare ...
Since the initial 1996 American Thoracic Society (ATS) guideline on nosocomial pneumonia, a number of new developments have appeared, mandating a new evidence-based guideline for hospital-acquired pneumonia (HAP), including healthcare-associated pneumonia (HCAP) and ventilator-associated pneumonia (VAP).
19 Ιουν 2024 · Hospital-acquired (or nosocomial) pneumonia (HAP) is an important cause of morbidity and mortality despite improved prevention, antimicrobial therapy, and supportive care [1]. The treatment of non-ventilator-associated HAP (nvHAP) and ventilator-associated pneumonia (VAP) will be reviewed here.
Abstract. Background Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and while European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP.
